ENSGHealthcare · Medical Care Facilities

ENSG Stock Forecast: The Ensign Group, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026

$182

−0.13% on the day

The 5 Wall Street analysts covering The Ensign Group, Inc. hold a median 12-month price target of $225 — +23.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 67 of 100 as at 13 Aug 2026 — in the upper half.

Market cap

$10.6B

Ticker Nerd rank

67 / 100

Median analyst target

$225

Analysts covering

Total return, dividends reinvested

−0.7%

+8.9%

YTD

+4.4%

+9.6%

From 52W high

−15.8%

From 52W low

+23.5%

$147

$216

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ENSG stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Ensign Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026

67 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility

Revisions

Quality

Growth

Momentum

Value

Issuance

Accruals

Size

Volatility (97): The share price has been relatively steady.

Accruals (32): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ENSG stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ENSG, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says5 analysts

4 Buy1 Hold0 Sell

Low $207Median $225High $230

The green dot is the last close — the median target sits +23.9% from it.

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
30 July 2026	Truist Securities	Maintains	Hold	$202 → $207
14 July 2026	Truist Securities	Maintains	Hold	$215 → $202
14 July 2026	Truist Securities	Maintains	Hold	—
9 Feb 2026	RBC Capital	Maintains	Outperform	—
6 Feb 2026	Truist Securities	Maintains	Hold	—
14 Nov 2025	RBC Capital	Maintains	Outperform	—
10 Nov 2025	Truist Securities	Maintains	Hold	—
5 Nov 2025	Stephens & Co.	Maintains	Overweight	—
5 Nov 2025	UBS	Maintains	Buy	—
2 Sept 2025	UBS	Maintains	Buy	—
14 Aug 2025	UBS	Maintains	Buy	—
28 July 2025	Stephens & Co.	Maintains	Overweight	—
28 July 2025	Truist Securities	Maintains	Hold	—
2 May 2025	Macquarie	Maintains	Outperform	—
7 Feb 2025	Stephens & Co.	Maintains	Overweight	—
6 Feb 2025	Stephens & Co.	Reiterates	Overweight	—
4 Feb 2025	Macquarie	Maintains	Outperform	—
6 Jan 2025	Truist Securities	Maintains	Hold	—
21 Nov 2024	UBS	Initiates	Buy	—
28 Oct 2024	RBC Capital	Maintains	Outperform	—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ENSG appears on the weeks it earns a place.

Estimates

ENSG analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

EPS revision, 90 days

+3.7%

Analysts raising

Analysts cutting

Fundamentals

The Ensign Group, Inc. (ENSG) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 28.5×
Price / sales: 1.9×
Price / book: 4.3×
EV / EBITDA: 21.3×

Growth & margins

Revenue growth (YoY): 17.3%
Earnings growth (YoY): 18.2%
Gross margin: 16.6%
Operating margin: 9.0%
Net margin: 6.9%

Returns & dividend

Return on equity: 17.0%
Return on assets: 5.5%
Dividend yield: 0.1%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ENSG vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities

Company	Market cap	TKN rank
ENSGThe Ensign Group, Inc.	$10.6B	67
UHSUniversal Health Services, Inc.	$10.7B	65
DVADaVita, Inc.	$12.0B	90
EHCEncompass Health Corp.	$12.3B	81
CHEChemed Corp.	$7.2B	87
PACSPACS Group, Inc.	$7.0B	93
THCTenet Healthcare Corp.	$21.5B	96

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Ensign Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ENSG news & analysis

Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws

Newsfile Corp · 14 Aug 2026negative

Kaplan Fox & Kilsheimer LLP announced it is investigating The Ensign Group, Inc. for potential violations of federal securities laws. The firm is seeking information from Ensign investors who have suffered losses or who may have information relevant to the investigation.

Why it matters — A securities investigation into Ensign signals potential legal and regulatory scrutiny that could affect the company's standing with investors.

Kaplan Fox & Kilsheimer LLP is Investigating The Ensign Group, Inc. (ENSG) for Possible Securities Law Violations

Newsfile Corp · 12 Aug 2026negative

Kaplan Fox & Kilsheimer LLP announced it is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for possible securities law violations. The firm is requesting that Ensign investors who have suffered losses or have relevant information contact them.

Why it matters — A securities-law investigation by a law firm introduces legal and regulatory uncertainty for Ensign shareholders.

Carillon Eagle Small Cap Growth Fund Q2 2026 Portfolio Review

Seeking Alpha · 11 Aug 2026neutral

The Carillon Eagle Small Cap Growth Fund reviewed its Q2 2026 portfolio, noting strong performance from Bloom Energy and the optical industry, while Karman's stock lagged after a below-expectation quarter on organic growth.

Why it matters — As a holding in many small-cap growth funds, ENSG's relative performance and investor sentiment can be influenced by the fund's portfolio commentary and sector trends highlighted in such reviews.

Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws

Newsfile Corp · 7 Aug 2026negative

Kaplan Fox & Kilsheimer LLP has announced it is investigating The Ensign Group for potential violations of federal securities laws. The law firm is seeking information from Ensign investors who have suffered losses or who may have relevant information.

Why it matters — The investigation raises the possibility that Ensign may have engaged in conduct that violated securities laws, which could lead to litigation or regulatory consequences for the company.

Lowey Dannenberg, P.C. is Investigating The Ensign Group (NASDAQ: ENSG) for Potential Violations of the Federal Securities Laws

GlobeNewsWire · 6 Aug 2026negative

Lowey Dannenberg P.C. announced it is investigating The Ensign Group for potential violations of the federal securities laws. The law firm said it is looking into whether the company may have engaged in conduct that could give rise to claims by investors.

Why it matters — A securities-law investigation by a prominent investor-rights firm signals potential legal exposure for Ensign that ENSG watchers would want to monitor.

FAQ

Frequently asked questions about ENSG stock

What is the ENSG stock price forecast for 2026-2027?

The 5 Wall Street analysts covering The Ensign Group, Inc. have a median 12-month price target of $225, with estimates ranging from $207 to $230. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ENSG stock a buy right now?

Of the 5 analysts covering The Ensign Group, Inc., 4 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Ensign Group, Inc. 67 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ENSG?

As at 13 Aug 2026, The Ensign Group, Inc. ranks 67 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (97 of 100).

Will ENSG stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +23.9% from the last close, and Ticker Nerd's factor model ranks The Ensign Group, Inc. 67 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ENSG stock forecast for 2030?

No analyst covering The Ensign Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ENSG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $207 to $230 over the next 12 months.

How has ENSG stock performed over the past year?

The Ensign Group, Inc. returned +9.6% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Ensign Group, Inc. do?

The Ensign Group, Inc. is a healthcare services holding company that operates through a network of independent subsidiaries across the United States.

What is the latest news on ENSG?

The most recent item we track (Newsfile Corp, 14 Aug 2026): "Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws". Kaplan Fox & Kilsheimer LLP announced it is investigating The Ensign Group, Inc. for potential violations of federal securities laws. The firm is seeking information from Ensign investors who have suffered losses or who may have information relevant to the investigation.

Company

About The Ensign Group, Inc.

The Ensign Group, Inc. is a healthcare services holding company that operates through a network of independent subsidiaries across the United States. The company focuses on post-acute care, providing skilled nursing, senior living, and rehabilitative services, including physical, occupational, and speech therapies, as well as various other healthcare and ancillary services. Its operations are organized primarily into skilled services and a real estate segment, with facilities offering short-term transitional care, long-term nursing care, and assisted living options in multiple states. In addition to clinical care, The Ensign Group, Inc. invests in, owns, and leases healthcare real estate used by its operating subsidiaries, supporting the post-acute care continuum. Ancillary businesses include mobile diagnostics, medical transportation, long-term care pharmacy, and consulting services, which complement its core facility-based operations. Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group, Inc. plays a significant role in the U.S. post-acute and senior care market by combining healthcare operations with strategic real estate ownership and services infrastructure.

CEO Mr. Barry R. Port · 46,000 employees · United States · https://ensigngroup.net